• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用积极手术方法并进行主要血管切除治疗腹膜后肉瘤。

Aggressive surgical approach with major vascular resection for retroperitoneal sarcomas.

作者信息

Li Yiyuan, Zhao Jichun, Huang Bin, Du Xiaojiong, Hu Hankui, Guo Qiang

机构信息

Division of Vascular Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu , Sichuan Province, China.

出版信息

PLoS One. 2025 Mar 20;20(3):e0320066. doi: 10.1371/journal.pone.0320066. eCollection 2025.

DOI:10.1371/journal.pone.0320066
PMID:40111953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11957768/
Abstract

BACKGROUND

En bloc resection of adjacent structures, including major vessels, is often required to achieve negative margins in retroperitoneal sarcoma (RPS). However, the effect of vascular involvement and different reconstruction techniques in patients undergoing vascular resection remains unclear. This study investigated the morbidity, mortality, and long-term survival of patients who underwent an aggressive surgical approach with vascular resection for RPS.

METHODS

We analyzed a prospectively maintained database of patients who underwent surgical resection (with or without vascular resection) for RPS between 2015 and 2020. The primary endpoint was long-term overall survival (OS).

FINDINGS

The study population comprised 252 patients. Postoperative morbidity, mortality, and OS did not differ significantly between the vascular and no vascular resection groups. Among patients with vascular involvement, those who underwent aggressive surgical approach with vascular resection had a significantly higher OS (66.3 months vs. 25.6 months) compared to those who underwent palliative resection, without an increase in mortality or complication rate. No significant differences were observed in postoperative morbidity, 30-day mortality, or estimated median OS between patients who underwent primary repair and reconstruction.

CONCLUSIONS

In patients with RPS with vascular involvement, an aggressive surgical approach with vascular resection achieved optimal clinical outcomes. Vascular reconstruction techniques had no impact on clinical outcomes.

摘要

背景

在腹膜后肉瘤(RPS)中,为实现切缘阴性,常常需要整块切除包括主要血管在内的相邻结构。然而,血管受累及不同重建技术对接受血管切除患者的影响仍不明确。本研究调查了接受积极手术方法联合血管切除治疗RPS患者的发病率、死亡率和长期生存率。

方法

我们分析了一个前瞻性维护的数据库,该数据库包含2015年至2020年间接受RPS手术切除(有或无血管切除)的患者。主要终点是长期总生存(OS)。

结果

研究人群包括252例患者。血管切除组和非血管切除组之间的术后发病率、死亡率和OS无显著差异。在血管受累的患者中,与接受姑息性切除的患者相比,接受积极手术方法联合血管切除的患者OS显著更高(66.3个月对25.6个月),且死亡率或并发症发生率没有增加。接受一期修复和重建的患者之间在术后发病率、30天死亡率或估计中位OS方面未观察到显著差异。

结论

在血管受累的RPS患者中,积极手术方法联合血管切除可实现最佳临床结局。血管重建技术对临床结局无影响。

相似文献

1
Aggressive surgical approach with major vascular resection for retroperitoneal sarcomas.采用积极手术方法并进行主要血管切除治疗腹膜后肉瘤。
PLoS One. 2025 Mar 20;20(3):e0320066. doi: 10.1371/journal.pone.0320066. eCollection 2025.
2
Clinical results of surgery for retroperitoneal sarcoma with major blood vessel involvement.伴有主要血管受累的腹膜后肉瘤手术的临床结果。
J Vasc Surg. 2006 Jul;44(1):46-55. doi: 10.1016/j.jvs.2006.03.001.
3
Aggressive surgical approach with vascular resection and reconstruction for retroperitoneal sarcomas: a systematic review.腹膜后肉瘤的积极手术方法:血管切除和重建的系统评价。
BMC Surg. 2023 Sep 12;23(1):275. doi: 10.1186/s12893-023-02178-1.
4
Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high‑volume sarcoma center: a propensity score matching analysis.高容量肉瘤中心腹膜后脂肪肉瘤的主要血管切除的手术结果:倾向评分匹配分析。
J Cancer Res Clin Oncol. 2024 Jul 9;150(7):343. doi: 10.1007/s00432-024-05871-7.
5
Outcomes of arterial bypass preceding resection of retroperitoneal masses involving major vessels.涉及大血管的腹膜后肿块切除术前动脉搭桥的结果。
J Surg Res. 2018 Oct;230:34-39. doi: 10.1016/j.jss.2018.04.039. Epub 2018 May 15.
6
Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.泰国一家大学医院对腹膜后软组织肉瘤的手术治疗经验。
J Med Assoc Thai. 2014 Jun;97(6):598-614.
7
Impact of three-dimensional-printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score-matched study.三维打印技术指导对腹膜后肉瘤手术结局的影响:一项倾向评分匹配研究。
Cancer. 2025 Jan 1;131(1):e35452. doi: 10.1002/cncr.35452. Epub 2024 Jul 3.
8
Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.低容量医院的治疗与腹膜后肉瘤患者的短期和长期预后降低有关。
Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.
9
Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.腹膜后肉瘤切除术后长期生存的结局及预测因素分析。
BMC Surg. 2019 Jun 10;19(1):61. doi: 10.1186/s12893-019-0521-9.
10
Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.腹膜后肉瘤初次扩大切除术后复发后的结局:跨大西洋腹膜后肉瘤工作组的报告
Cancer. 2017 Jun 1;123(11):1971-1978. doi: 10.1002/cncr.30572. Epub 2017 Feb 2.

本文引用的文献

1
Incidence, risk factors, and outcomes of venous thromboembolism in patients undergoing surgery for retroperitoneal tumors: a propensity-matched retrospective cohort study.接受腹膜后肿瘤手术患者静脉血栓栓塞症的发生率、风险因素和结局:一项倾向评分匹配的回顾性队列研究。
Int J Surg. 2023 Sep 1;109(9):2689-2695. doi: 10.1097/JS9.0000000000000429.
2
Survival outcomes of surgery for retroperitoneal sarcomas: A systematic review and meta-analysis.腹膜后肉瘤手术治疗的生存结局:系统评价和荟萃分析。
PLoS One. 2022 Jul 28;17(7):e0272044. doi: 10.1371/journal.pone.0272044. eCollection 2022.
3
Oncological outcomes after major vascular resections for primary retroperitoneal liposarcoma.
原发性腹膜后脂肪肉瘤的大血管切除术后的肿瘤学结果。
Eur J Surg Oncol. 2021 Dec;47(12):3004-3010. doi: 10.1016/j.ejso.2021.06.035. Epub 2021 Jul 2.
4
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.成人原发性腹膜后肉瘤(RPS)的治疗:来自跨大西洋澳大拉西亚 RPS 工作组的最新共识方法。
Ann Surg Oncol. 2021 Nov;28(12):7873-7888. doi: 10.1245/s10434-021-09654-z. Epub 2021 Apr 14.
5
Crucial Roles of Vascular Surgeons in Oncovascular and Non-Vascular Surgery.血管外科医生在肿瘤血管和非血管手术中的关键作用。
Eur J Vasc Endovasc Surg. 2020 Nov;60(5):764-771. doi: 10.1016/j.ejvs.2020.08.026. Epub 2020 Oct 8.
6
Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.复发性腹膜后肉瘤:手术治疗的临床结果和预后因素。
Eur J Surg Oncol. 2021 May;47(5):1201-1206. doi: 10.1016/j.ejso.2020.08.030. Epub 2020 Sep 9.
7
Multidisciplinary Oncovascular Surgery is Safe and Effective in the Treatment of Intra-abdominal and Retroperitoneal Sarcomas: A Retrospective Single Centre Cohort Study and a Comprehensive Literature Review.多学科联合腹盆部肉瘤外科治疗:回顾性单中心队列研究及文献复习
Eur J Vasc Endovasc Surg. 2020 Nov;60(5):752-763. doi: 10.1016/j.ejvs.2020.05.029. Epub 2020 Jul 31.
8
Radical excision for retroperitoneal soft tissue sarcoma: A national propensity-matched outcomes analysis.腹膜后软组织肉瘤的根治性切除术:全国倾向匹配结局分析。
Surgery. 2020 Nov;168(5):831-837. doi: 10.1016/j.surg.2020.05.031. Epub 2020 Jul 21.
9
A Multidisciplinary Approach to Oncological Resections with Vascular Surgeons Improves Patient Outcomes.多学科联合血管外科手术提高肿瘤切除术患者的预后。
Eur J Vasc Endovasc Surg. 2020 Aug;60(2):293-299. doi: 10.1016/j.ejvs.2020.04.011. Epub 2020 May 8.
10
Oncovascular Surgery and the Making of the Oncovascular Surgeon.肿瘤血管外科学与肿瘤血管外科医生的培养
Vasc Specialist Int. 2019 Dec;35(4):189-192. doi: 10.5758/vsi.2019.35.4.189. Epub 2019 Dec 31.